TDF Long Term Study

• Status: Completed
• Trial end date: 2013-08-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will assess the safety and efficacy of generic TDF from Governmental Pharmaceutical Organization (GPO) in HIV-infected children

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The HIV Netherlands Australia Thailand Research Collaboration
• Collaborators: Bamrasnaradura Infectious Diseases Institute; Chulalongkorn University
• Treatments: Tenofovir

Criteria

Inclusion Criteria:

• children who are changing to TDF due to adherence problem or treatment failure

• children who are already on TDF due to their clinical indication

Exclusion Criteria:

• child/caretaker refuse to participate in this study

• cannot adhere to the study schedule